Dr. Greg Steinbock, MD

Urology Jeffersonville, IN Male
NPI: 1972590057
Total Payments
$158,571
2023 Payments
$5,843
Companies
49
Transactions
866
Medicare Patients
4,545
Medicare Billing
$1.9M

Payment Breakdown by Category

Other$92,068 (58.1%)
Consulting$29,744 (18.8%)
Food & Beverage$19,906 (12.6%)
Travel$11,662 (7.4%)
Research$4,685 (3.0%)
Education$505.77 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Current or prospective ownership or investment interest $71,662 7 45.2%
Consulting Fee $29,744 10 18.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,406 11 12.9%
Food and Beverage $19,906 785 12.6%
Travel and Lodging $11,662 39 7.4%
Unspecified $4,685 6 3.0%
Education $505.77 8 0.3%

Payments by Type

General
$153,886
860 transactions
Research
$4,685
5 transactions
Ownership
$0
1 transactions

Top Paying Companies

Company Total Records Latest Year
Whip Mix Corporation $71,662 8 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $24,061 122 $0 (2023)
Janssen Biotech, Inc. $13,372 149 $0 (2023)
Astellas Pharma US Inc $10,344 112 $0 (2023)
Merck Sharp & Dohme LLC $10,279 33 $0 (2023)
PFIZER INC. $8,156 52 $0 (2023)
Mission Pharmacal Company $4,685 5 $0 (2018)
Dendreon Pharmaceuticals LLC $3,363 145 $0 (2023)
Clovis Oncology, Inc. $2,332 7 $0 (2020)
Exelixis Inc. $1,980 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2023 $5,843 65 Merck Sharp & Dohme LLC ($4,892)
2022 $60,986 198 Whip Mix Corporation ($41,114)
2021 $11,508 111 Whip Mix Corporation ($7,626)
2020 $25,258 92 Whip Mix Corporation ($10,161)
2019 $30,532 170 Whip Mix Corporation ($12,760)
2018 $19,604 135 Janssen Biotech, Inc. ($6,499)
2017 $4,839 95 Mission Pharmacal Company ($1,285)

All Payment Transactions

866 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
12/06/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $7.36 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
12/05/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $143.53 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
08/05/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $11.26 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
07/14/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $16.97 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
06/15/2023 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $17.08 General
Category: Oncology
06/12/2023 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $27.12 General
Category: ONCOLOGY
06/12/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $12.39 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
06/08/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Food and Beverage In-kind items and services $15.25 General
Category: Oncology
06/08/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $12.01 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
06/06/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $10.94 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
06/06/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $6.94 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
06/05/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $4.47 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
05/25/2023 Axonics, Inc. Axonics (Device) Food and Beverage In-kind items and services $16.56 General
Category: Urology
05/24/2023 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $24.88 General
Category: Oncology
05/19/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $4.63 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
05/12/2023 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $19.59 General
Category: HORMONE THERAPY
05/11/2023 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $24.59 General
Category: Oncology
05/11/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $13.42 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
05/10/2023 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $11.81 General
Category: ONCOLOGY
05/04/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $10.74 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
05/04/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $2.57 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
05/03/2023 Progenics Pharmaceuticals, Inc. PYLARIFY (Drug) Food and Beverage In-kind items and services $20.08 General
Category: RADIOPHARMACEUTICAL
05/02/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $19.41 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
04/28/2023 Foundation Medicine, Inc. FOUNDATIONONE LIQUID CDX (Device) Food and Beverage In-kind items and services $13.24 General
Category: Oncology
04/27/2023 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $5.89 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
123…35»

Research Studies & Clinical Trials

Study Name Company Amount Records
MPC-SHRC-002 Mission Pharmacal Company $4,460 4
MPC-COGNITIVE ASSESSMENT - 02 Mission Pharmacal Company $225.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 438 6,430 $429,601 $178,702
2022 29 1,305 15,304 $2.2M $1.0M
2021 28 1,499 19,891 $941,423 $405,990
2020 24 1,303 17,228 $716,574 $275,728
Total Patients
4,545
Total Services
58,853
Medicare Billing
$1.9M
Procedure Codes
91

All Medicare Procedures & Services

91 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J1952 Leuprolide injectable, camcevi, 1 mg Office 2023 35 1,470 $273,420 $107,854 39.4%
J0897 Injection, denosumab, 1 mg Office 2023 38 2,640 $92,400 $46,357 50.2%
J9155 Injection, degarelix, 1 mg Office 2023 11 1,840 $12,880 $5,817 45.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 86 103 $14,317 $5,676 39.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 55 61 $12,505 $4,664 37.3%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 20 98 $11,760 $4,380 37.2%
84153 Psa (prostate specific antigen) measurement, total Office 2023 90 103 $5,356 $1,856 34.7%
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 55 66 $4,422 $1,459 33.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 37 37 $1,665 $335.72 20.2%
84403 Testosterone (hormone) level, total Office 2023 11 12 $876.00 $303.48 34.6%
Q2043 Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion Office 2022 11 17 $1.3M $716,511 53.4%
J0897 Injection, denosumab, 1 mg Office 2022 54 4,740 $165,900 $81,179 48.9%
J1952 Leuprolide injectable, camcevi, 1 mg Office 2022 22 924 $171,864 $68,896 40.1%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2022 45 273 $120,120 $37,997 31.6%
J3315 Injection, triptorelin pamoate, 3.75 mg Office 2022 12 72 $52,560 $19,314 36.7%
J9155 Injection, degarelix, 1 mg Office 2022 24 5,280 $36,960 $15,886 43.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 129 169 $34,645 $14,390 41.5%
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies Office 2022 82 82 $52,316 $14,035 26.8%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2022 23 172 $20,640 $8,053 39.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 103 132 $18,348 $7,437 40.5%
J9280 Injection, mitomycin, 5 mg Office 2022 16 153 $42,720 $5,843 13.7%
J9030 Bcg live intravesical instillation, 1 mg Office 2022 34 2,293 $12,360 $4,880 39.5%
51720 Instillation of anti-cancer drug into bladder Office 2022 50 82 $18,204 $4,771 26.2%
51797 Insertion of device into abdomen with pressure and urine flow rate study Office 2022 31 31 $8,060 $4,445 55.2%
84153 Psa (prostate specific antigen) measurement, total Office 2022 131 200 $10,400 $3,611 34.7%
1234»

About Dr. Greg Steinbock, MD

Dr. Greg Steinbock, MD is a Urology healthcare provider based in Jeffersonville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972590057.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Steinbock, MD has received a total of $158,571 in payments from pharmaceutical and medical device companies, with $5,843 received in 2023. These payments were reported across 866 transactions from 49 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($71,662).

As a Medicare-enrolled provider, Steinbock has provided services to 4,545 Medicare beneficiaries, totaling 58,853 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Other Specialties Urology
  • Location Jeffersonville, IN
  • Active Since 10/04/2005
  • Last Updated 10/24/2007
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1972590057

Products in Payments

  • XTANDI (Drug) $15,734
  • Nubeqa (Drug) $13,417
  • Erleada (Drug) $12,139
  • Xofigo (Drug) $10,644
  • LYNPARZA (Biological) $9,839
  • VeriSplint (Medical Supply) $7,626
  • PROVENGE (Drug) $3,418
  • RUBRACA (Drug) $2,250
  • CABOMETYX (Drug) $1,980
  • ERLEADA (Drug) $1,634
  • INTERSTIM (Device) $1,199
  • Endocare Cryocare System (Medical Supply) $989.01
  • Axumin (Drug) $787.92
  • Prolia (Biological) $505.06
  • KEYTRUDA (Biological) $440.77
  • XGEVA (Biological) $397.47
  • Xtandi (Drug) $349.52
  • FOUNDATIONONE (Device) $344.98
  • LUPRON DEPOT (Drug) $249.24
  • XIAFLEX (Biological) $233.13

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Jeffersonville

James Bailen, Md, MD

Urology — Payments: $285,803

Urology $285,803

William Schmied, Md, MD

Urology — Payments: $117,556

Urology $117,556

Ryan Malone, M.d, M.D

Urology — Payments: $58,538

Urology $58,538

Barry Pecha, Md, MD

Urology — Payments: $46,502

Urology $46,502

Ganesh Rao, Md, MD

Urology — Payments: $21,724

Urology $21,724

Bradley Bell, Md, MD

Urology — Payments: $15,268

Urology $15,268